Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation

Canadian Journal of Emergency Medicine

Volumn 8, Issue 1, 2006, Pages 13-18

  Auer, Johann ^a   Berent, Robert ^a   Weber, Thomas ^a   Porodko, Michael ^a   Lamm, Gudrun ^a   Lassnig, Elisabeth ^a   Maurer, Edwin ^a   Mayr, Herbert ^a   Punzengruber, Christian ^a   Eber, Bernd ^a  

^a GENERAL HOSPITAL   (Austria)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Neuron specific enolase; Outcome; Predictive value of tests; Prognosis

Indexed keywords

NEURON SPECIFIC ENOLASE;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BRAIN ISCHEMIA; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; DEATH; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; MALE; PROGNOSIS; REFERENCE VALUE; RESUSCITATION; SURVIVAL RATE;

EID: 33645470657     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/S1481803500013324     Document Type: Article

References (35)

1. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-90.
2. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
3. Longstreth WT Jr, Diehr P, Inui TS. Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 1983;308:1378-82.
4. Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxic-ischemic coma. JAMA 1985;253:1420-6.
5. Scollo-Lavizzari G, Bassetti C. Prognostic value of EEG in post-anoxic coma after cardiac arrest. Eur Neurol 1987;26:161-70.
6. Brunko E, Zegers de Beyl D. Prognostic value of early cortical somatosensory evoked potentials after resuscitation from cardiac arrest. Electroencephalogr Clin Neurophysiol 1987;66:15-24.
7. Madl C, Grimm G, Kramer L, et al. Early prediction of individual outcome after cardiopulmonary resuscitation. Lancet 1993; 341:855-8.
8. Morimoto Y, Kemmotsu O, Kitami K, et al. Acute brain swelling after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med 1993;21:104-10.
9. Rupright J, Woods EA, Singh A. Hypoxic brain injury: evaluation by single photon emission computed tomography. Arch Phys Med Rehabil 1996;77:1205-8.
10. Vaagenes P, Mullie A, Fodstad DT, et al. The use of cytosolic enzyme increase in cerebrospinal fluid of patients resuscitated after cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. Am J Emerg Med 1994;12:621-4.
11. Karkela J, Pasanen M, Kaukinen S, et al. Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Crit Care Med 1992;20:378-86.
12. Hans P, Bonhomme V, Collette J, et al. Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: Assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage. J Neurosurg Anesthesiol 1993;5:111-6.
13. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987; 10:269-95.
14. Steinberg R, Gueniau C, Scarna H, et al. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem 1984;43:19-24.
15. Schmechel D, Marangos PJ, Zis AP, et al. Brain enolases as specific markers of neuronal and glial cells. Science 1978; 199:313-5.
16. Schmechel D, Marangos PJ, Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978;276:834-6.
17. Schoerkhuber W, Kittler H, Sterz F, et al. Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 1999;30:1598-603.
18. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18:911-8.
19. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994;25:558-65.
20. Mabe H, Suzuki S, Mase M, et al. Serum neuron-specific enolase levels after subarachnoid hemorrhage. Surg Neurol 1991; 36:170-4.
21. Barone FC, Clark RK, Price WJ, et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res 1993;623:77-82.
22. Cunningham RT, Watt M, Winder J, et al. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest 1996;26:298-303.
23. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29:2363-6.
24. Dauberschmidt R, Zinsmeyer J, Mrochen H, et al. Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol 1991;14:237-45.
25. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133-8.
26. Bassetti C, Bomio F, Mathis J, et al. Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients. J Neurol Neurosurg Psychiatry 1996;61:610-5.
27. Herrmann M, Ebert AD, Galazky I, et al. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke 2000;31:645-50.
28. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-4.
29. Koller-Strametz J, Fritzer M, Gwechenberger M, et al. Elevation of prostate-specific markers after cardiopulmonary resuscitation. Circulation 2000;102:290-3.
30. Jacobs P, Noseworthy TW. National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 1990;18:1282-6.
31. Martens P, Haymerle A, Sterz F, et al. Limitation of life support after resuscitation from cardiac arrest: practice in Belgium and Austria. Resuscitation 1997;35:123-8.
32. Stelzl T, von Bose MJ, Hogl B, et al. A comparison of the prognostic value of neuron-specific enolase serum levels and somatosensory evoked potentials in 13 reanimated patients. Eur J Emerg Med 1995;2:24-7.
33. Burghuber OC, Worofka B, Schernthaner G, et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990;65:1386-90.
34. Zeltzer PM, Marangos PJ, Evans AE, et al. Serum neuron-specific enolase in children with neuroblastoma: relationship to stage and disease course. Cancer 1986;57:1230-4.
35. D'Alessandro M, Mariani P, Lomanto D, et al. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors. Tumour Biol 1992; 13:352-7.